Topic:

Chutes and Ladders

Latest Headlines

Latest Headlines

AbbVie's senior R&D exec Leonard joins exodus from the top ranks

The epidemic of retirements among top R&D executives is continuing with the news that AbbVie's senior researcher is headed for the exits. AbbVie filed forms with the SEC on Friday saying that John Leonard, the company's senior vice president and CSO will be leaving in the coming months. And the company says that one of his last acts will be advising the company on his successor.

Dunsire out as Takeda rolls Millennium into its global R&D operations

CEO Deborah Dunsire is retiring from Millennium, the unit Takeda bought about 5 years ago, as Millennium's oncology R&D is rolled up into the parent company's global research organization.

UPDATED: Deborah Dunsire exits as Takeda cuts CEO role in Millennium shakeup

Millennium CEO Deborah Dunsire is retiring and her business development chief Anna Protopapas will step in to head the oncology business of Takeda Pharmaceutical. The Japanese drugmaker revealed the management shakeup in a terse announcement today.

Moderna taps biotech legend Henri Termeer for board of directors

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email |...

Ex-Genzyme chief Termeer joins board at Cambridge biotech

Moderna, which struck a major development deal with AstraZeneca just months after it shed stealth status, has landed former Genzyme CEO Henri Termeer for the board of directors

Biotech legend Termeer joins the board at Moderna

The biotech, which struck a major development deal with AstraZeneca just months after it shed stealth status, has landed former Genzyme CEO Henri Termeer for the board of directors.

Symonds steps down as Novartis CFO, Kirsch takes over

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email |...

Novartis changes CFOs, reveals cuts to workforce and chairman pay

While the U.S. government was announcing its kickbacks lawsuit against Novartis, the Swiss drugmaker was putting the finishing touches on a few press releases of its own.

Busy Novartis announces layoffs, taps new CFO and slashes chairman's pay

While the U.S. government was announcing its kickbacks lawsuit against Novartis, the Swiss drugmaker was putting the finishing touches on a few press releases of its own.

AEterna Zentaris brings on David Dodd as new CEO

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email |...